Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega-3 Supplementation for Liver Volume Reduction in Bariatric Surgery
NCT03006016Completed
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Apr 2017
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Hepatomegaly and hepatic steatosis comparing Omega 3 with Placebo (2 arms). Primary endpoint: Volume of the left liver lobe at 4 weeks. Started Apr 2017; status: completed.
02
Drugs
omega-3-acid triglycerides
03
Conditions
Hepatomegalyhepatic steatosis
Beyond the preview
Go deeper on NCT03006016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03006016.